Metformin Cost in New Hampshire 2026

What Does Metformin Actually Cost at New Hampshire Pharmacies in 2026?

The average cash-pay price for generic metformin at New Hampshire retail pharmacies sits at approximately $8 per month in 2026, compared with the nominal manufacturer list price of $40 per month. That gap exists because metformin has been off-patent for decades, giving generic manufacturers room to compete aggressively on price.

The FDA first approved metformin hydrochloride immediate-release tablets in 1994 under the brand name Glucophage, and extended-release formulations followed in 2000 [1]. With generics now manufactured by more than a dozen companies, retail competition in states like New Hampshire keeps prices low even for uninsured patients.

Prices vary by pharmacy chain and quantity dispensed. A 30-day supply of metformin 500 mg twice daily (60 tablets) at a large chain such as CVS or Walgreens typically runs $10 to $18 without any coupon. Walmart's $4 generic drug program lists metformin 500 mg as a qualifying medication, dropping a 30-day supply to $4 and a 90-day supply to $10 for patients who pay cash at the pharmacy counter [2]. Hannaford and Market Basket pharmacies, both common in New Hampshire, frequently price 90-day supplies at $9 to $12 without a coupon.

The landmark UKPDS 34 trial (N=1,704 overweight patients with newly diagnosed type 2 diabetes) demonstrated that metformin reduced any diabetes-related endpoint by 32% relative to diet alone (P<0.001) and cut all-cause mortality by 36% (P<0.001) over a median 10.7-year follow-up [3]. That evidence base is part of why metformin remains the first-line oral agent recommended in current American Diabetes Association (ADA) Standards of Care [4]. Widespread generic availability means that one of the most evidence-supported glucose-lowering agents is also one of the least expensive.

For patients on a fixed income, even $8 per month can add up. The sections below cover every cost-reduction pathway available in New Hampshire.

Does New Hampshire Medicaid Cover Metformin?

New Hampshire Medicaid (NH Medicaid, administered through the Department of Health and Human Services) does not currently list metformin as a covered benefit for prediabetes prevention alone. Patients with a confirmed type 2 diabetes diagnosis may qualify for metformin coverage under NH Medicaid's preferred drug list, but prior authorization requirements and formulary tiers vary by managed care organization [5].

New Hampshire's Medicaid expansion under the Affordable Care Act extended coverage to adults up to 138% of the federal poverty level [6]. Patients enrolled through NH Medicaid should confirm metformin's tier placement directly with their plan, since some managed care contracts update formularies quarterly.

The ADA's 2024 Standards of Care state: "Metformin remains the preferred initial pharmacologic agent for the treatment of type 2 diabetes in most patients" [4]. Despite that consensus, state Medicaid programs retain independent authority over formulary inclusion, and New Hampshire has not adopted a blanket prediabetes prevention drug benefit as of 2026.

Patients enrolled in Medicare Part D should check their specific plan's formulary. Metformin appears on the CMS model formulary as a protected-class drug for diabetes, meaning most Part D plans cover at least one metformin formulation at Tier 1 or Tier 2 [7]. The out-of-pocket cost after the Medicare Part D $2,000 annual cap (effective 2025 under the Inflation Reduction Act) is typically $0 to $10 per month for metformin [8].

Is Compounded Metformin Legal in New Hampshire?

Yes. New Hampshire permits 503A compounding pharmacies to prepare patient-specific metformin formulations legally, provided the pharmacy holds a valid state pharmacy license and operates under a valid prescription from a licensed prescriber [9]. This is not a regulatory gray area. The FDA's guidance on 503A compounding pharmacies explicitly allows compounding of FDA-approved drug substances, including metformin, for individual patients [10].

A 503A pharmacy differs from a 503B outsourcing facility. A 503A pharmacy dispenses compounded drugs to specific patients with a prescription; a 503B facility can distribute to hospitals and clinics without patient-specific prescriptions [10]. Most telehealth-connected compounding pharmacies operating in New Hampshire are 503A entities.

The practical cost of compounded metformin through a telehealth program can be as low as $0 per month when bundled with a subscription-based care model. Some programs charge a flat monthly membership fee that includes the prescription, provider visit, and compounded medication. Patients should verify that any compounding pharmacy is licensed with the New Hampshire Board of Pharmacy before filling a prescription [11].

Compounded formulations sometimes combine metformin with other agents such as berberine or combine immediate-release and extended-release pellets in a single capsule. These combinations are not FDA-approved products and have not been evaluated in large randomized trials. Patients should discuss the evidence base for any non-standard formulation with their prescribing provider before starting.

How New Hampshire Insurance Plans Cover Metformin

Most commercial insurance plans sold through the New Hampshire Marketplace (healthcare.gov) cover generic metformin at Tier 1 (the lowest cost-sharing tier), meaning typical copays of $0 to $10 per 30-day fill [12]. Employer-sponsored plans in New Hampshire largely mirror this structure, though high-deductible health plans (HDHPs) may require patients to pay cash price until the deductible is met.

The Affordable Care Act requires non-grandfathered plans to cover preventive services rated A or B by the U.S. Preventive Services Task Force (USPSTF) without cost-sharing. The USPSTF issued a B recommendation in 2021 for prediabetes screening in adults aged 35 to 70 who are overweight or obese [13]. However, the USPSTF recommendation for metformin in prediabetes prevention is categorized differently from a preventive screening service, so cost-sharing exemptions do not automatically apply to the drug itself.

Patients with commercial insurance should request a formulary exception if metformin is placed on a higher tier than Tier 1. Generic metformin is inexpensive enough that most plans approve Tier 1 placement without a fight, but extended-release branded formulations such as Glumetza can sit at Tier 3 or higher, carrying $50 to $150 monthly copays without prior authorization for the generic substitute.

The HealthRX Clinical Team uses a four-step insurance navigation framework for New Hampshire metformin patients:

1. Confirm the generic (not brand) is prescribed. Extended-release generic metformin ER is therapeutically equivalent to Glucophage XR per FDA substitution tables [1].
2. Request a 90-day supply. Most NH insurance plans reduce the per-unit copay when dispensing a 90-day supply versus three separate 30-day fills.
3. Ask for a formulary exception letter if the plan places metformin above Tier 1. The prescriber's office can submit a one-page medical necessity letter citing the ADA Standards of Care [4].
4. Compare the insurance copay to the GoodRx or RxSaver coupon price. At many NH pharmacies, the coupon price undercuts the insurance copay.

GoodRx, Manufacturer Coupons, and Other Discount Programs in New Hampshire

GoodRx coupons reduce the retail cash price of generic metformin at New Hampshire pharmacies by 60% to 80% in most cases. At a CVS or Rite Aid in Manchester or Concord, a GoodRx coupon for metformin 500 mg (60 tablets) typically brings the price to $4 to $7 [14]. The coupon is free to obtain at GoodRx.com and does not require enrollment in any plan.

RxSaver, NeedyMeds, and FamilyWize offer competing discount cards with similar pricing. Patients should compare two or three coupon prices at their preferred pharmacy before filling, since reimbursement contracts differ by chain.

NeedyMeds maintains a database of patient assistance programs for New Hampshire residents, including manufacturer-sponsored programs for patients whose income falls below 400% of the federal poverty level [15]. Because metformin is generic, brand-name manufacturer coupons (which historically applied to Glucophage) are no longer widely available. Generic manufacturers do not typically offer patient assistance programs, which is why the cash price and coupon price are the primary pathways.

The New Hampshire Charitable Foundation and several county-level community health centers in New Hampshire operate medication assistance programs that can cover metformin for uninsured patients who do not qualify for Medicaid [16]. Concord's Capital Region Public Health Network and Manchester Community Health Center are two local resources worth contacting directly.

The DPP (Diabetes Prevention Program) trial (N=3,234) showed that metformin 850 mg twice daily reduced progression from prediabetes to type 2 diabetes by 31% over 2.8 years compared with placebo (P<0.001), and that lifestyle intervention reduced progression by 58% [17]. Because metformin's evidence in prediabetes is established, some New Hampshire primary care providers and telehealth platforms prescribe it off-label for prediabetes prevention at the same low generic price.

Can You Get Metformin via Telehealth in New Hampshire?

Telehealth prescribing of metformin is fully legal in New Hampshire. The state's telehealth statute (RSA 328-F) permits synchronous audio-video encounters to establish a valid prescriber-patient relationship and supports controlled-substance and non-controlled prescription authority for licensed New Hampshire providers [18]. Metformin is not a controlled substance, so it carries none of the additional restrictions that apply to Schedule IV or V medications.

A telehealth visit for a metformin prescription typically costs $0 to $75 depending on insurance coverage and the platform. Patients with Medicaid or commercial insurance may owe nothing if the plan covers telehealth visits for chronic disease management. Cash-pay telehealth platforms such as those in the HealthRX network often bundle the provider visit, lab interpretation, and prescription into a single monthly fee.

The American Diabetes Association notes that telemedicine approaches to diabetes management can be "effective in improving glycemic control" and recommends that clinicians consider telehealth for patients with limited access to in-person care [4]. Rural New Hampshire residents in Coos, Carroll, and Grafton counties, where endocrinologist access is limited, stand to benefit most from telehealth-based metformin management.

After the telehealth visit, the prescriber sends a prescription electronically to the patient's chosen pharmacy, including mail-order pharmacies. Mail-order fills of a 90-day metformin supply through plans like Express Scripts or CVS Caremark typically carry a $0 to $5 copay for Tier 1 generics [19].

Dosing, Side Effects, and When to Monitor Kidney Function

Metformin is dosed orally, typically starting at 500 mg once or twice daily with food to minimize gastrointestinal side effects, with gradual titration to a maintenance dose of 1 to 000 mg twice daily for most adults [1]. The extended-release formulation taken once daily at dinner reduces nausea and diarrhea in many patients and may improve adherence, though it costs slightly more than the immediate-release tablet.

The FDA label for metformin includes a boxed warning for lactic acidosis, a rare but serious adverse effect occurring primarily in patients with significantly impaired renal function [1]. Current FDA guidance contraindicates metformin use when estimated glomerular filtration rate (eGFR) falls below 30 mL/min/1.73 m2 and recommends reassessing the benefit-risk profile when eGFR falls between 30 and 45 mL/min/1.73 m2 [1]. The FDA updated its renal guidance in 2016, replacing the older serum creatinine cutoffs with eGFR thresholds [20].

The ADA recommends checking renal function (serum creatinine and eGFR) at least annually in all patients taking metformin and more frequently if baseline eGFR is between 45 and 60 mL/min/1.73 m2 [4]. Vitamin B12 deficiency is a recognized long-term effect of metformin use. The DPP Outcomes Study found that participants taking metformin had a significantly higher prevalence of B12 deficiency than placebo participants after 5 years [21]. Periodic B12 monitoring is reasonable in patients on long-term metformin therapy, particularly those aged 65 and older.

Gastrointestinal side effects, including nausea, diarrhea, and abdominal discomfort, affect roughly 20% to 30% of patients initiating metformin and are the most common reason for discontinuation [22]. Taking metformin with the largest meal of the day and starting at the lowest available dose reduces these effects for most patients.

Metformin for Weight Management and Longevity in New Hampshire Patients

Metformin is occasionally prescribed off-label for weight management, polycystic ovary syndrome (PCOS), and aging-related metabolic concerns. Evidence supports modest weight reduction. A 2012 Cochrane review of metformin for PCOS found a mean body weight reduction of approximately 3 kg compared with placebo over 6 months [23]. For obesity without diabetes, the effect is smaller.

The ongoing TAME (Targeting Aging with Metformin) trial, funded by the American Federation for Aging Research, is evaluating metformin's effect on age-related diseases in adults aged 65 to 79 across multiple US sites [24]. Results are expected in the late 2020s. Until TAME data are available, prescribing metformin solely for longevity or anti-aging purposes in non-diabetic, non-prediabetic patients sits outside current FDA-approved indications and ADA guidelines [4].

For PCOS, the Endocrine Society's 2023 Clinical Practice Guideline states: "We suggest metformin as a treatment for menstrual irregularity and hyperandrogenism in women with PCOS who have not responded to lifestyle intervention and for whom oral contraceptives are contraindicated or not preferred" [25]. At New Hampshire pharmacies, a metformin prescription for PCOS costs the same $8 per month cash price as for diabetes.

Comparing Metformin Prices at New Hampshire Pharmacies: Retail, Mail-Order, and Compounding

The table below summarizes 2026 estimated prices at common New Hampshire pharmacy channels for a 30-day supply of metformin 500 mg, twice daily (60 tablets):

• CVS (cash, no coupon): approximately $12 to $18
• Walgreens (cash, no coupon): approximately $11 to $17
• Walmart $4 Program: $4 (30-day), $10 (90-day) [2]
• Hannaford / Market Basket: approximately $9 to $12 for 90-day supply
• GoodRx coupon at any major NH chain: $4 to $7 [14]
• CVS Caremark mail-order (Tier 1 insured): $0 to $5 per 90-day supply [19]
• 503A compounding pharmacy via telehealth bundle: $0 (included in membership fee)

Mail-order remains the least expensive option for insured patients. The 503A compounding route through a telehealth subscription may match or beat mail-order for uninsured or underinsured patients, provided the compounded formulation matches the patient's clinical needs.

One factor worth considering: compounded metformin is not bioequivalence-tested to the FDA-approved reference product [10]. For straightforward type 2 diabetes management, the FDA-approved generic tablet is the clinically validated choice. Compounded formulations may offer advantages in dose-flexibility or delivery-method customization for specific patients, but that decision should involve a licensed prescriber familiar with the patient's full clinical picture.

The Diabetes Prevention Program Outcomes Study (DPPOS) 15-year follow-up (N=1,990 original DPP participants) confirmed that metformin continued to reduce diabetes incidence by 18% relative to placebo even after 15 years (P<0.001), with a favorable safety profile throughout [26]. Cost-effectiveness analyses based on DPPOS data estimate that metformin-based prediabetes prevention saves $2,650 per quality-adjusted life-year gained compared with no intervention [27]. At $8 per month, the economic case for keeping New Hampshire patients on metformin long-term is difficult to dispute.